solifenacin succinate has been researched along with Sjogren's Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SH; Chen, DY; Chen, HX; Chou, EC; Huang, CM; Huang, CP; Huang, PH; Lan, JL; Wu, PC; Yeo, KJ | 1 |
1 trial(s) available for solifenacin succinate and Sjogren's Syndrome
| Article | Year |
|---|---|
Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms-A randomized controlled trial.
Topics: Acetanilides; Drug Therapy, Combination; Humans; Muscarinic Antagonists; Sjogren's Syndrome; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2023 |